Agenus Corporate Update and Fourth Quarter & Full Year 2020 Financial Report

NEXT STORY
Eledon Pharmaceuticals Strengthens Leadership Team with Chief Medical Officer and Chief Financial Officer Hires
PREV STORY
Rubius Therapeutics Reports Initial Clinical Data from Ongoing Phase 1/2 Trial of RTX-240 in Patients with Advanced Solid Tumors, Demonstrating Single-Agent Activity
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Installation of Elekta’s sixth high-field MR-adaptive linear accelerator initiated at The Christie

Research to focus on the use of MR-adapted radiotherapy in patients with lung cancer ...

author_avatar
NASDAQ Market News

Iovance Biotherapeutics Announces Results of a Subgroup Analysis of Patients in the Lifileucel Metastatic Melanoma Study who are Primary Refractory to Anti-PD-1/L1 Therapy

author_avatar
NASDAQ Market News

Myovant Sciences and HealthyWomen Launch Storytelling Initiative to Elevate Conversations About Menstrual Health

author_avatar
NASDAQ Market News